CPI Card Group(PMTS) - 2025 Q1 - Earnings Call Presentation
2025-05-07 11:03
Non-GAAP Financial Measures In addition to financial results reported in accordance with U.S. generally accepted accounting principles ("GAAP"), we have provided the following non-GAAP financial measures in this release, all reported on a continuing operations basis: EBITDA, Adjusted EBITDA, Adjusted EBITDA margin, Free Cash Flow, LTM Adjusted EBITDA and Net Leverage Ratio. These non-GAAP financial measures are utilized by management in comparing our operating performance on a consistent basis between fisca ...
Uber(UBER) - 2025 Q1 - Earnings Call Presentation
2025-05-07 10:58
Uber Technologies, Inc. Q1 2025 Earnings Supplemental Data May 7, 2025 1 Non-GAAP Financial Measures Disclosure To supplement our financial information, which is prepared and presented in accordance with generally accepted accounting principles in the United States of America, or GAAP, we use the following non-GAAP financial measures: Adjusted EBITDA; Non-GAAP Costs and Operating Expenses; Trailing Twelve Months Adjusted EBITDA; Trailing Twelve Months Free Cash Flow; Free Cash Flow as well as revenue growth ...
RXO(RXO) - 2025 Q1 - Earnings Call Presentation
2025-05-07 10:36
First Quarter 2025 Results May 7, 2025 Non-GAAP financial measures and forward-looking statements Non-GAAP financial measures We provide reconciliations of the non-GAAP financial measures contained in this presentation to the most directly comparable measure under GAAP, which are set forth in the financial tables attached to this presentation. The non-GAAP financial measures in this presentation include: adjusted earnings before interest, taxes, depreciation and amortization ("adjusted EBITDA"); bank-adjust ...
SuRo Capital(SSSS) - 2025 Q1 - Earnings Call Presentation
2025-05-07 07:24
Q1 2025 Earnings Call May 6, 2025 2 First Quarter 2025 Q1 2025 Earnings Overview • New Portfolio Company Investment o Plaid Inc.(3) – $5.0 million investment Forward Looking Statements Statements included herein, including statements regarding SuRo Capital Corp.'s ("SuRo Capital", "SSSS", the "Company", "we", "us" or "our") beliefs, expectations, intentions or strategies for the future, may constitute "forward-looking statements". SuRo Capital cautions you that forward-looking statements are not guarantees ...
Beta Bionics Inc(BBNX) - 2025 Q1 - Earnings Call Presentation
2025-05-07 04:54
Q1 2025 Earnings May 6, 2025 Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this presentation that are not statements of historical fact are forward-looking statements. Such forward-looking statements include, without limitation, statements regarding: expectations of Beta Bionics, Inc. (the "Company") regarding our regulatory development plans for the iLet and other product candidates; the markets and ...
Varonis(VRNS) - 2025 Q1 - Earnings Call Presentation
2025-05-07 01:18
Varonis Overview This presentation contains "forward-looking statements," including statements concerning plans, objectives, goals, strategies, future events or performance, growth prospects, capital resources, expenditures and underlying assumptions and other statements, which are other than statements of historical facts. Actual outcomes and results could differ materially from those forecasts due to the impact of many factors beyond the control of the Company and its affiliates. The words "believe", "exp ...
Teradata(TDC) - 2025 Q1 - Earnings Call Presentation
2025-05-07 01:16
This release contains forward-looking statements within the meaning of Section 21E of the Securities and Exchange Act of 1934. Forward-looking statements generally relate to opinions, beliefs, and projections of expected future financial and operating performance, business trends, liquidity, and market conditions, among other things. These forward-looking statements are based upon current expectations and assumptions and often can be identified by words such as "expect," "strive," "looking ahead," "outlook, ...
Sarepta Therapeutics(SRPT) - 2025 Q1 - Earnings Call Presentation
2025-05-07 01:15
Patients can't wait for the next breakthrough in medical research. So neither will we. First Quarter 2025 Financial Results Tuesday, May 6, 2025 MELANIE Living with limb-girdle muscular dystrophy ©SAREPTA THERAPEUTICS, INC. 2025. ALL RIGHTS RESERVED. 1 This presentation includes both GAAP information and Non-GAAP information. Non-GAAP (loss) income is defined as GAAP net (loss) income excluding interest income, net, depreciation and amortization expense, stock-based compensation expense, loss (gain) on stra ...
Corpay, Inc.(CPAY) - 2025 Q1 - Earnings Call Presentation
2025-05-07 01:13
Q1 2025 Earnings Release Supplement Refer to earnings release dated May 6, 2025 for further information ^ - dark blue-teal #00B5E2 ^ - light raspberry #981239 ^ - dark raspberry #981239 ^ - light blue-teal #59CBE8 ^ - cool gray 1 #E6E8E7 ^ - maroon #3D1628 Q1 Safe Harbor Provision 2025 ^ This presentation contains forward-looking statements within the meaning of the federal securities laws. Statements that are not historical facts, including statements about Corpay's (formerly known as Fleetcor Technologies ...
Atomera(ATOM) - 2025 Q1 - Earnings Call Presentation
2025-05-07 01:12
Q1 2025 Conference Call Atomera Incorporated 2 Mears Silicon Technology (MST®) Quantum Engineered Materials Transistor enhancement technology for the $600B semiconductor market High Leverage IP Licensing Business Model May 6, 2025 Atomera Incorporated 1 Safe Harbor This presentation contains forward-looking statements concerning Atomera Incorporated (""Atomera," the "Company," "we," "us," and "our"). The words "believe," "may," "will," "potentially," "estimate," "continue," "anticipate," "intend," "could," ...